Metastatic Recurrence in a Pancreatic Cancer Patient Derived Orthotopic Xenograft (PDOX) Nude Mouse Model Is Inhibited by Neoadjuvant Chemotherapy in Combination with Fluorescence-Guided Surgery with an Anti-CA 19-9-Conjugated Fluorophore

Efficacy ofSalmonella typhimuriumA1-R Versus Chemotherapy on a Pancreatic Cancer Patient-Derived Orthotopic Xenograft (PDOX)

(2014) Yukihiko Hiroshima et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Successful Fluorescence-Guided Surgery on Human Colon Cancer Patient-Derived Orthotopic Xenograft Mouse Models Using a Fluorophore-Conjugated Anti-CEA Antibody and a Portable Imaging System

(2014) Yukihiko Hiroshima et al.   Journal of Laparoendoscopic & Advanced Surgical Techniques

Comparison of a chimeric anti-carcinoembryonic antigen antibody conjugated with visible or near-infrared fluorescent dyes for imaging pancreatic cancer in orthotopic nude mouse models

(2013) Ali A. Maawy et al.   JOURNAL OF BIOMEDICAL OPTICS

Fluorescently labeled chimeric anti-CEA antibody improves detection and resection of human colon cancer in a patient-derived orthotopic xenograft (PDOX) nude mouse model

(2013) Cristina A. Metildi et al.   JOURNAL OF SURGICAL ONCOLOGY

Hand-held high-resolution fluorescence imaging system for fluorescence-guided surgery of patient and cell-line pancreatic tumors growing orthotopically in nude mice

(2013) Yukihiko Hiroshima et al.   JOURNAL OF SURGICAL RESEARCH

Putting Numbers to Fluorescent Guided Surgery

(2013) Eben L. Rosenthal et al.   MOLECULAR IMAGING AND BIOLOGY

Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicators

(2012) Matthew H. G. Katz et al.   CANCER

Fluorescence-Guided Surgery Allows for More Complete Resection of Pancreatic Cancer, Resulting in Longer Disease-Free Survival Compared with Standard Surgery in Orthotopic Mouse Models

(2012) Cristina A. Metildi et al.   JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS

Molecular Profiling of Direct Xenograft Tumors Established from Human Pancreatic Adenocarcinoma After Neoadjuvant Therapy

(2011) Michael P. Kim et al.   ANNALS OF SURGICAL ONCOLOGY

Glowing Tumors Make for Better Detection and Resection

(2011) M. Bouvet et al.   Science Translational Medicine

Serum CA19–9 Alterations During Preoperative Gemcitabine-Based Chemoradiation Therapy for Resectable Invasive Ductal Carcinoma of the Pancreas as an Indicator for Therapeutic Selection and Survival

(2010) Hidenori Takahashi et al.   ANNALS OF SURGERY

Serum CA 19-9 as a Marker of Resectability and Survival in Patients with Potentially Resectable Pancreatic Cancer Treated with Neoadjuvant Chemoradiation

(2010) Matthew H. G. Katz et al.   ANNALS OF SURGICAL ONCOLOGY

Prognostic Factors for Survival After Extended Pancreatectomy for Pancreatic Head Cancer

(2009) Koichi Kato et al.   PANCREAS

Preoperative Gemcitabine-Based Chemoradiation for Patients With Resectable Adenocarcinoma of the Pancreatic Head

(2008) Douglas B. Evans et al.   JOURNAL OF CLINICAL ONCOLOGY

Fluorophore-conjugated anti-CEA Antibody for the Intraoperative Imaging of Pancreatic and Colorectal Cancer

(2008) Sharmeela Kaushal et al.   JOURNAL OF GASTROINTESTINAL SURGERY

Imaging of Primary and Metastatic Pancreatic Cancer Using a Fluorophore-Conjugated Anti-CA19-9 Antibody for Surgical Navigation

(2008) Michele McElroy et al.   WORLD JOURNAL OF SURGERY